Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

755 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland.
McSorley LM, Tharmabala M, Al Rahbi F, Keane F, Evoy D, Geraghty JG, Rothwell J, McCartan DP, Greally M, O'Connor M, O'Mahony D, Keane M, Kennedy MJ, O'Reilly S, Millen SJ, Crown JP, Kelly CM, Prichard RS, Quinn CM, Walshe JM. McSorley LM, et al. Curr Oncol. 2024 Mar 1;31(3):1302-1310. doi: 10.3390/curroncol31030098. Curr Oncol. 2024. PMID: 38534931 Free PMC article.
Colony-stimulating factors for febrile neutropenia.
Kelly C, O'Mahony D, O'Reilly S. Kelly C, et al. N Engl J Med. 2013 Jul 18;369(3):284-5. doi: 10.1056/NEJMc1306109. N Engl J Med. 2013. PMID: 23863064 No abstract available.
Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland.
Smyth L, Watson G, Walsh EM, Kelly CM, Keane M, Kennedy MJ, Grogan L, Hennessy BT, O'Reilly S, Coate LE, O'Connor M, Quinn C, Verleger K, Schoeman O, O'Reilly S, Walshe JM. Smyth L, et al. Breast Cancer Res Treat. 2015 Oct;153(3):573-82. doi: 10.1007/s10549-015-3555-4. Epub 2015 Sep 12. Breast Cancer Res Treat. 2015. PMID: 26364296
Cancer Care Costs and Clinical Trials.
Kelly D, Brady C, Sui J, Cronin E, O'Hare D, Waldron J, O'Mahony D, Power D, Bambury RM, O'Reilly S. Kelly D, et al. Ir Med J. 2017 Apr 10;110(4):557. Ir Med J. 2017. PMID: 28665096 No abstract available.
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Colleoni M, Luo W, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Hitre E, Graas MP, Simoncini E, Kamby C, Thompson A, Loibl S, Gavilá J, Kuroi K, Marth C, Müller B, O'Reilly S, Di Lauro V, Gombos A, Ruhstaller T, Burstein H, Ribi K, Bernhard J, Viale G, Maibach R, Rabaglio-Poretti M, Gelber RD, Coates AS, Di Leo A, Regan MM, Goldhirsch A; SOLE Investigators. Colleoni M, et al. Lancet Oncol. 2018 Jan;19(1):127-138. doi: 10.1016/S1470-2045(17)30715-5. Epub 2017 Nov 17. Lancet Oncol. 2018. PMID: 29158011 Clinical Trial.
Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials Ireland.
Kearns C, Feighery R, Mc Caffrey J, Higgins M, Smith M, Murphy V, O'Reilly S, Horgan AM, Walshe J, McDermott R, Morris PG, Keane M, Martin M, Murphy C, Duffy K, Mihai A, Armstrong J, O'Donnell DM, Gallagher WM, Kelly CM, Kelly CM. Kearns C, et al. Cancers (Basel). 2020 Jul 16;12(7):1921. doi: 10.3390/cancers12071921. Cancers (Basel). 2020. PMID: 32708702 Free PMC article.
755 results